Browsing by Autor "Ronald palacios castrillo"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item type: Item , Comprehensive Insights Into Modrna Vaccines: persistent Pp-spike Recombinant Protein, Hyperimmune/inflammatory Reactions, Thrombotic Vasculopathy, Chronic Organ Complications, And Excess Deaths.(2024) Ronald palacios castrilloA recent study revealed a persistent presence of the PP-Spike recombinant protein in 50% of individuals who received ModRNA injections, contrasting with unvaccinated controls, whether SARSCoV-2 infected or not, up to 187 days post-injection. The implications of these findings are discussed in the context of PP-Spike recombinant protein-induced hyperimmune/inflammatory reactions and thrombotic vasculitis as mechanisms to elucidate the serious side effects, long-term organ complications, and excess deaths observed after administering Covid ModRNA products. These results underscore the urgent need for a comprehensive reassessment of the risk-benefit profile of ModRNA injections, including an immediate halt in their use for any person, and a renewed emphasis on understanding and addressing their long-term effects on human healthItem type: Item , Long-Term Organ Complications: The True Public Health Concern in SARSCoV-2 Infection(2023) Ronald palacios castrilloThe collective considerations presented here lead to a crucial question: What truly constitutes the primary public health challenge posed by SARSCoV-2 infection and its variants?The findings of Bowen et al.(1) and Noé et al.(4) have offered us new insights into the actual repercussions of SARSCoV-2 virus infections on public health. They unmistakably point to the late sequelae and complications arising as secondary effects of the viral infection, causing severe and long-term damage to global public health. Rather than the acute infection which has a very low mortality rate in the general population, as initially and commonly believed.Item type: Item , Unraveling the Tapestry: Immune Imprinting Amidst a Spectrum of Challenges for modRNA COVID-19 Vaccines(2023) Ronald palacios castrilloAmong the number of hurdles that the vaccines based in modRNA platforms have been facing, there is now another critical one: immune imprinting which decreases even more the effectiveness of the modRNA Covid vaccines.